 Adicet Bio is a biotechnology company concentrated on developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet has developed a pre-clinical pipeline of 4 therapeutics covering various indications with the lead two candidates ADI-001 and -002 being molecularly very similar offering lower clinical diversification. 